2222509-79-5
2222509-79-5
Chemical Structure
GSK-340
- CAS. Nr.: 2222509-79-5
- Formula:C26H31N3O2
- Molecular Weight:417.54
IUPAC Name: (S)-1-(2-cyclopropyl-4-(2-(hydroxymethyl)benzyl)-6-(1,2,3,6-tetrahydropyridin-4-yl)-3,4-dihydroquinoxalin-1(2H)-yl)ethan-1-one
InChIKey: ARWMKZDWGIOCEU-AREMUKBSSA-N
SMILES: CC(N1[C@@H](C2CC2)CN(CC3=CC=CC=C3CO)C4=C1C=CC(C5=CCNCC5)=C4)=O
Biological Activity: GSK-340 is a BET inhibitor with high affinity and significant selectivity for BD2 from BRD4 with a pIC50 of 7.2. GSK-340 inhibits MCP-1 release in Lipopolysaccharide (HY-D1056) treated PBMCs and whole blood with the pIC50 of 7.4 and 6.0, respectively. GSK-340 has immunomodulatory activity[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GSK-340 | GSK-340 is a BET inhibitor with high affinity and significant selectivity for BD2 from BRD4 with a pIC50 of 7.2. GSK-340 inhibits MCP-1 release in Lipopolysaccharide (HY-D1056) treated PBMCs and whole blood with the pIC50 of 7.4 and 6.0, respectively. GSK-340 has immunomodulatory activity. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
